Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines

Latent infection of Epstein-Barr virus (EBV) is associated with a poor prognosis in patients with B cell malignancy. We examined whether dasatinib, a multi kinase inhibitor, which is broadly used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia is effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotaki, Ryutaro, Kawashima, Masaharu, Yamamoto, Yuichiro, Higuchi, Hiroshi, Nagashima, Etsuko, Kurosaki, Natsumi, Takamatsu, Masako, Kikuti, Yara Yukie, Imadome, Ken-Ichi, Nakamura, Naoya, Kotani, Ai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062761/
https://www.ncbi.nlm.nih.gov/pubmed/32152351
http://dx.doi.org/10.1038/s41598-020-61300-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062761/
https://www.ncbi.nlm.nih.gov/pubmed/32152351
http://dx.doi.org/10.1038/s41598-020-61300-y

Ejemplares similares